• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床与病理 TNM 分类的不相符:对喉癌患者治疗结果和预后的影响。

Discordance between clinical and pathological TNM classification: influence on results of treatment and prognosis in patients with laryngeal cancer.

出版信息

Neoplasma. 2017;64(2):305-310. doi: 10.4149/neo_2017_219.

DOI:10.4149/neo_2017_219
PMID:28052684
Abstract

The goals of this retrospective cohort study were to compare the results of clinical and pathological TNM staging in patients with laryngeal squamous cell carcinoma and to determine the impact of the discordance on prognosis and treatment results. A total of 124 patients with laryngeal cancer, primarily indicated for surgical treatment, were enrolled. The concordance or discordance between the clinical and pathological staging was compared with the frequency of cancer relapse and disease-specific survival. Other potential prognostic factors, like age, the stage and location of the primary tumor, the status of neck lymph nodes, histological margins, and an indication for postoperative radiotherapy, were also evaluated. A disparity in at least one component of TNM staging was found in 40 patients (32%). The discordance had significant negative influence on both disease-free survival (DSF) and disease-specific survival (DSS). Other significant negative prognostic factors were the stage of the primary tumor, nodal status and postoperative radiotherapy. Our results indicate that the discordance between clinical and pathological staging affects the results of cancer treatment significantly. Some improvement can be probably achieved with higher preoperative diagnostic method accuracy.

摘要

本回顾性队列研究的目的是比较喉鳞状细胞癌患者的临床和病理 TNM 分期结果,并确定分期不一致对预后和治疗结果的影响。共纳入 124 例主要接受手术治疗的喉癌患者。比较了临床和病理分期的一致性或不一致性与癌症复发和疾病特异性生存率的频率。还评估了其他潜在的预后因素,如年龄、原发肿瘤的分期和位置、颈部淋巴结状态、组织学切缘以及术后放疗的指征。在 40 名患者(32%)中发现至少一个 TNM 分期成分存在差异。分期不一致对无病生存率(DFS)和疾病特异性生存率(DSS)均有显著的负面影响。其他显著的负性预后因素包括原发肿瘤的分期、淋巴结状态和术后放疗。我们的结果表明,临床和病理分期之间的不一致会显著影响癌症治疗的结果。通过提高术前诊断方法的准确性,可能会有一定程度的改善。

相似文献

1
Discordance between clinical and pathological TNM classification: influence on results of treatment and prognosis in patients with laryngeal cancer.临床与病理 TNM 分类的不相符:对喉癌患者治疗结果和预后的影响。
Neoplasma. 2017;64(2):305-310. doi: 10.4149/neo_2017_219.
2
[Discordance between Clinical and Pathological TNM Classifications in Patients with Oropharyngeal Cancer - Influence on Treatment and Prognosis].
Klin Onkol. 2016;29(2):122-6.
3
Discrepancy between clinical and pathological staging of laryngeal carcinoma: a dilemma to be solved.喉癌临床分期与病理分期的差异:亟待解决的难题。
Eur Arch Otorhinolaryngol. 2024 May;281(5):2507-2513. doi: 10.1007/s00405-024-08506-2. Epub 2024 Feb 12.
4
[Long term results of partial laryngectomies in patients suffering from laryngeal cancer].[喉癌患者行部分喉切除术的长期结果]
Otolaryngol Pol. 2012 Jan-Feb;66(1):46-50. doi: 10.1016/S0030-6657(12)70749-7.
5
Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer.接受复发性/持续性喉癌放疗后挽救性喉手术患者的颈部处理
Laryngoscope. 2006 Oct;116(10):1864-6. doi: 10.1097/01.mlg.0000234917.08822.cd.
6
Clinical and molecular prognostic factors in operable laryngeal cancer.可手术喉癌的临床及分子预后因素
Eur Arch Otorhinolaryngol. 2005 Nov;262(11):890-8. doi: 10.1007/s00405-005-0916-3. Epub 2005 Mar 1.
7
A Critical Reappraisal of Primary and Recurrent Advanced Laryngeal Cancer Staging.对原发性和复发性晚期喉癌分期的批判性重新评估。
Ann Otol Rhinol Laryngol. 2019 Jan;128(1):36-43. doi: 10.1177/0003489418806915. Epub 2018 Oct 26.
8
[Retrospective analysis of 760 laryngeal squamous cell carcinoma patients treated with open laryngeal function-preserving operations].760例喉鳞状细胞癌患者行开放性喉功能保留手术的回顾性分析
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 May;32(10):737-744. doi: 10.13201/j.issn.1001-1781.2018.10.004.
9
Management of T3N1 glottic carcinoma: therapeutic outcomes.T3N1期声门癌的治疗:治疗结果
Laryngoscope. 2006 Jan;116(1):106-10. doi: 10.1097/01.mlg.0000184767.62682.3d.
10
Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.声门上型癌喉部分切除术后放疗致喉水肿的意义
J Otolaryngol Head Neck Surg. 2008 Oct;37(5):681-8.

引用本文的文献

1
Surgery of T1/2 N0 M0 glottic cancer results in a better laryngeal preservation time compared to radiotherapy in a large German patient cohort.在一个大型德国患者队列中,与放射治疗相比,T1/2 N0 M0声门癌手术可带来更长的喉保留时间。
Eur Arch Otorhinolaryngol. 2025 Jun 14. doi: 10.1007/s00405-025-09460-3.
2
Clinical and Pathological Staging Discrepancies in Laryngeal Cancer: A Systematic Review.喉癌的临床与病理分期差异:一项系统评价
Cancers (Basel). 2025 Jan 28;17(3):455. doi: 10.3390/cancers17030455.
3
Study of the significance of the combination of the fibrinogen-albumin ratio and sarcopenia in predicting the prognosis of laryngeal cancer patients undergoing radical surgery.
纤维蛋白原-白蛋白比值与肌肉减少症联合预测行根治性手术的喉癌患者预后的意义研究。
BMC Cancer. 2024 Oct 11;24(1):1265. doi: 10.1186/s12885-024-13039-2.
4
Discrepancy between clinical and pathological staging of laryngeal carcinoma: a dilemma to be solved.喉癌临床分期与病理分期的差异:亟待解决的难题。
Eur Arch Otorhinolaryngol. 2024 May;281(5):2507-2513. doi: 10.1007/s00405-024-08506-2. Epub 2024 Feb 12.
5
Comparison of Clinical and Pathological Staging in Patients with Head and Neck Cancer After Neck Dissection.颈部解剖术后头颈癌患者临床分期与病理分期的比较。
Int Arch Otorhinolaryngol. 2023 Sep 14;27(4):e571-e578. doi: 10.1055/s-0042-1758208. eCollection 2023 Oct.
6
Comparison Between Clinical and Pathological Staging After Elective Neck Dissection in Head and Neck Cancer.头颈癌选择性颈清扫术后临床分期与病理分期的比较
Cureus. 2023 Jun 24;15(6):e40881. doi: 10.7759/cureus.40881. eCollection 2023 Jun.
7
The role of adjuvant therapy in pT4N0 laryngectomized patients: Multicentric observational study.辅助治疗在 pT4N0 喉切除术后患者中的作用:多中心观察性研究。
Head Neck. 2023 Jan;45(1):197-206. doi: 10.1002/hed.27225. Epub 2022 Oct 17.
8
Time between Diagnosis and Treatment of Hypopharynx and Larynx Cancer: Are Longer Delays Associated with Higher Discrepancy between Clinical and Pathological Staging?下咽癌和喉癌诊断与治疗之间的时间间隔:较长的延迟是否与临床分期和病理分期之间的较高差异相关?
Int Arch Otorhinolaryngol. 2021 Jan;25(1):e108-e114. doi: 10.1055/s-0040-1708898. Epub 2020 May 4.
9
Surgical nodal management in hypopharyngeal and laryngeal cancer.下咽癌和喉癌的外科淋巴结处理。
Eur Arch Otorhinolaryngol. 2020 May;277(5):1481-1489. doi: 10.1007/s00405-020-05838-7. Epub 2020 Feb 11.
10
Clinical and pathological stage discordance among 433,514 breast cancer patients.433514 例乳腺癌患者的临床与病理分期差异。
Am J Surg. 2019 Oct;218(4):669-676. doi: 10.1016/j.amjsurg.2019.07.016. Epub 2019 Jul 18.